NCT02084160View on ClinicalTrials.gov

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

CompletedOBSERVATIONAL
Enrollment

579

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2018

Study Completion Date

November 30, 2018

Conditions
Chronic Liver Disease
Trial Locations (4)

29425

Medical University of South Carolina, Charleston

48202

Henry Ford Health System, Detroit

Unknown

Virginia Commonwealth University, Richmond

Hadassah Medical Origanzation, Jerusalem

Sponsors
All Listed Sponsors
lead

Meridian Bioscience, Inc.

INDUSTRY